Literature DB >> 34423275

Tetramethoxystilbene Inhibits NLRP3 Inflammasome Assembly via Blocking the Oligomerization of Apoptosis-Associated Speck-like Protein Containing Caspase Recruitment Domain: In Vitro and In Vivo Evaluation.

Mohd Abdullaha1,2, Mehboob Ali2,3, Dilpreet Kour2,3, Ramesh Mudududdla1,2, Parul Khajuria2,3, Ajay Kumar2,3, Sandip B Bharate1,2.   

Abstract

Nucleotide-binding domain leucine-rich repeat family pyrin domain containing 3 (NLRP3) inflammasome complex regulates the caspase-1 activity and subsequent processing of interleukin-1β (IL-1β). Various inflammatory diseases involve the activation of inflammasome complexes; thus, the intervention in complex formation via small molecules offers a new therapeutic opportunity. The structure-guided design and synthesis of a series of methoxystilbenes and methoxy-2-phenylnaphthalenes identified new inhibitors of NLRP3 inflammasome complex. The tetramethoxystilbene 4o and trimethoxy 2-phenylnaphthalene 1t inhibit the release of a mature form of IL-1β in J774A.1 cells with IC50 values of 1.39 and 2.07 μM, respectively. Mechanistic investigation revealed that tetramethoxystilbene 4o blocks the oligomerization of apoptosis-associated speck-like protein (ASC), which is the vital step in the formation of NLRP3 inflammasome assembly, thus preventing the activation of caspase-1 and the IL-1β release. Treatment of LPS+ATP challenged mice with 20 mg/kg of 4o significantly suppressed the levels of IL-1β. The data presented herein warrant further investigation of methoxystilbenes in disease-specific models of inflammatory diseases.
© 2021 American Chemical Society.

Entities:  

Year:  2021        PMID: 34423275      PMCID: PMC8369685          DOI: 10.1021/acsptsci.1c00126

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  42 in total

1.  Syntheses of hydroxy substituted 2-phenyl-naphthalenes as inhibitors of tyrosinase.

Authors:  Suhee Song; Hyojin Lee; Youngeup Jin; Young Mi Ha; Sungjin Bae; Hae Young Chung; Hongsuk Suh
Journal:  Bioorg Med Chem Lett       Date:  2006-10-12       Impact factor: 2.823

2.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

3.  Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis.

Authors:  Chunqing Guo; Jacob W Fulp; Yuqi Jiang; Xia Li; Jeremy E Chojnacki; Jingde Wu; Xiang-Yang Wang; Shijun Zhang
Journal:  ACS Chem Neurosci       Date:  2017-07-13       Impact factor: 4.418

4.  ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.

Authors:  Richard E Mewshaw; Richard J Edsall; Cuijian Yang; Eric S Manas; Zhang B Xu; Ruth A Henderson; James C Keith; Heather A Harris
Journal:  J Med Chem       Date:  2005-06-16       Impact factor: 7.446

Review 5.  Inflammasomes.

Authors:  Marcel R de Zoete; Noah W Palm; Shu Zhu; Richard A Flavell
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-16       Impact factor: 10.005

6.  Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling.

Authors:  Joseph A Duncan; Daniel T Bergstralh; Yanhong Wang; Stephen B Willingham; Zhengmao Ye; Albert G Zimmermann; Jenny Pan-Yun Ting
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

7.  3,4-methylenedioxy-β-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome.

Authors:  Yuan He; Saranyaraajan Varadarajan; Raúl Muñoz-Planillo; Aaron Burberry; Yuumi Nakamura; Gabriel Núñez
Journal:  J Biol Chem       Date:  2013-11-21       Impact factor: 5.157

8.  The role of the NLRP3 inflammasome in gout.

Authors:  Sarah R Kingsbury; Philip G Conaghan; Michael F McDermott
Journal:  J Inflamm Res       Date:  2011-03-13

9.  17β-Estradiol Regulates Microglia Activation and Polarization in the Hippocampus Following Global Cerebral Ischemia.

Authors:  Roshni Thakkar; Ruimin Wang; Jing Wang; Ratna K Vadlamudi; Darrell W Brann
Journal:  Oxid Med Cell Longev       Date:  2018-04-18       Impact factor: 6.543

10.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

Authors:  Rebecca C Coll; Avril A B Robertson; Jae Jin Chae; Sarah C Higgins; Raúl Muñoz-Planillo; Marco C Inserra; Irina Vetter; Lara S Dungan; Brian G Monks; Andrea Stutz; Daniel E Croker; Mark S Butler; Moritz Haneklaus; Caroline E Sutton; Gabriel Núñez; Eicke Latz; Daniel L Kastner; Kingston H G Mills; Seth L Masters; Kate Schroder; Matthew A Cooper; Luke A J O'Neill
Journal:  Nat Med       Date:  2015-02-16       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.